Marshall Wace North America’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$114M	Buy	188,467 +129,839	+221%	+$80.6M	0.49%	40
2021 Q2	$32.7M	Buy	58,628 +45,916	+361%	+$23.3M	0.14%	156
2021 Q1	$6.01M	Buy	12,712 +10,374	+444%	+$5.05M	0.03%	515
2020 Q4	$1.13M	Buy	+2,338	New	+$1.26M	0.01%	912
2020 Q3	–	Sell	-54,475	Closed	-$34M	–	1430
2020 Q2	$34M	Buy	54,475 +43,413	+392%	+$24.6M	0.22%	113
2020 Q1	$5.4M	Buy	11,062 +8,433	+321%	+$3.48M	0.04%	303
2019 Q4	$987K	Buy	+2,629	New	+$885K	﹤0.01%	716
2019 Q1	–	Sell	-131	Closed	-$49K	–	1843
2018 Q4	$49K	Buy	+131	New	+$47.9K	﹤0.01%	1257
2018 Q3	–	Sell	-14,764	Closed	-$5.09M	–	1291
2018 Q2	$5.09M	Buy	14,764 +5,386	+57%	+$1.68M	0.03%	504
2018 Q1	$3.23M	Buy	+9,378	New	+$3.26M	0.02%	674
2017 Q2	–	Sell	-1,977	Closed	-$767K	–	1434
2017 Q1	$767K	Buy	+1,977	New	+$733K	0.01%	745
2013 Q4	$9.84M	Buy	+35,766	New	+$10.3M	0.21%	115